HSP 90 inhibitors, IPI-504 and AT13387 can decrease the KIT protein level, showing obvious antitumor activity in GIST as a single agent, and they are more potent when in combination with IM or sunitinib [54, 204]. Here, KIT is linked to gastrointestinal stromal tumor.